Brian T. Crum

Brian T. Crum

Senior Vice President and General CounselatLexicon Pharmaceuticals· In proxies 2021–2024

Pay in FY2024+1% from the year before · Lexicon Pharmaceuticals stock -51.7% the same year

Brian T. Crum was paid $1.4M in FY2024 (Dec), up 1%. Lexicon Pharmaceuticals stock fell 51.7% that year.

Pay$100 in the stock at the end of FY20 → $22
Pay is from the Summary Compensation Table of each Lexicon Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Lexicon PharmaceuticalsPublic company · 5 yr
    • Senior Vice President and General Counsel2021 – Present · 5 yrStock in role -57%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?